{"id":4081,"date":"2025-09-02T14:51:10","date_gmt":"2025-09-02T14:51:10","guid":{"rendered":"https:\/\/veraqueconsulting.com\/mx\/?p=4081"},"modified":"2025-09-02T14:53:29","modified_gmt":"2025-09-02T14:53:29","slug":"simplification-agreement-impact-on-equivalency-pathways","status":"publish","type":"post","link":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/","title":{"rendered":"Simplification Agreement: Impact on Mexico\u2019s Medical Device Equivalency Pathways"},"content":{"rendered":"<p class=\"ai-optimize-6 ai-optimize-introduction\"><span data-contrast=\"auto\">When seeking sanitary registration for medical devices in Mexico through COFEPRIS, companies have traditionally followed one of two routes: the ordinary process or the fast-track equivalency agreements. From those, the equivalency pathway has become a central topic of discussion following the implementation of the <\/span><a href=\"https:\/\/veraqueconsulting.com\/mx\/mexicos-expanded-equivalency-agreement-for-medical-devices-key-implications\/\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">Expanded Equivalency Agreement.<\/span><\/a> <span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-7\"><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-8\"><span data-contrast=\"auto\">This article outlines the implications of the <\/span><a href=\"https:\/\/www.dof.gob.mx\/nota_detalle.php?codigo=5766390&amp;fecha=22\/08\/2025#gsc.tab=0\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">recently published Simplification Agreement<\/span><\/a><span data-contrast=\"auto\">, which officially renders previous equivalency agreements obsolete as of <\/span><b><span data-contrast=\"auto\">October 3, 2025<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-9\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3 class=\"ai-optimize-10\"><strong>Background: Shifting Regulatory Pathways in Mexico\u00a0<\/strong><\/h3>\n<p>&nbsp;<\/p>\n<p class=\"ai-optimize-11\"><span data-contrast=\"auto\">Until recently, the two main registration options were<\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-12\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"4\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><b><span data-contrast=\"auto\">Ordinary\/ Standard\u00a0 Registration Process<\/span><\/b><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li class=\"ai-optimize-13\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"4\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><b><span data-contrast=\"auto\">Equivalency Agreements<\/span><\/b><span data-contrast=\"auto\"> (commonly referred to as <\/span><i><span data-contrast=\"auto\">fast-track approvals<\/span><\/i><span data-contrast=\"auto\">)<\/span><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-14\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-15\"><span data-contrast=\"auto\">However, on <\/span><b><span data-contrast=\"auto\">August 22, 2025<\/span><\/b><span data-contrast=\"auto\">, the Official Mexican Gazette<\/span> <span data-contrast=\"auto\">published the <\/span><a href=\"https:\/\/www.dof.gob.mx\/nota_detalle.php?codigo=5766390&amp;fecha=22\/08\/2025#gsc.tab=0\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">Simplification Agreement for Procedures at COFEPRIS.<\/span><\/a><span data-contrast=\"auto\"> This regulation introduces major changes, most notably on the<\/span><b><span data-contrast=\"auto\"> elimination of prior equivalency agreements.<\/span><\/b><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-16\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3 class=\"ai-optimize-17\"><b><span data-contrast=\"auto\">Obsolete Agreements: What is Being Phased Out?<\/span><\/b><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h3>\n<p>&nbsp;<\/p>\n<p class=\"ai-optimize-18\"><span data-contrast=\"auto\">Since 2010 and 2012, Mexico had adopted equivalency models recognizing regulatory authorizations from:<\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-19\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Canada<\/span><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li class=\"ai-optimize-20\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">United States<\/span><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li class=\"ai-optimize-21\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"3\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">Japan<\/span><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-22\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-23\"><span data-contrast=\"auto\">Each pathway had a designated unique procedure code (homoclave) for submission. Under <\/span><b><span data-contrast=\"auto\">Article 6<\/span><\/b><span data-contrast=\"auto\"> of the Simplification Agreement, these codes will be removed, effectively retiring:<\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-24\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><a href=\"https:\/\/dof.gob.mx\/nota_detalle.php?codigo=5164641&amp;fecha=26\/10\/2010#gsc.tab=0\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">The U.S. and Canada Equivalency Agreement<\/span><\/a><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li class=\"ai-optimize-25\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"2\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><a href=\"https:\/\/www.dof.gob.mx\/nota_detalle.php?codigo=5231033&amp;fecha=25\/01\/2012#gsc.tab=0\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">The Japan Equivalency Agreement<\/span><\/a><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-26\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3 class=\"ai-optimize-27\"><b><span data-contrast=\"auto\">The New Pathway: Expanded Equivalency Agreement<\/span><\/b><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h3>\n<p>&nbsp;<\/p>\n<p class=\"ai-optimize-28\"><span data-contrast=\"auto\">In response, COFEPRIS has introduced a single, unified pathway for equivalency-based registration:<\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li class=\"ai-optimize-29\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559682&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Code COFEPRIS-04-050: <\/span><i><span data-contrast=\"auto\">Application for Sanitary Registration of Medical Devices via Equivalency with Reference Regulatory Authorities<\/span><\/i><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/li>\n<\/ul>\n<p class=\"ai-optimize-30\"><span data-contrast=\"auto\">This new route incorporates reference authorities aligned with MDSAP and IMDRF as detailed in our previous article: <\/span><a href=\"https:\/\/veraqueconsulting.com\/mx\/mexicos-expanded-equivalency-agreement-for-medical-devices-key-implications\/\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">Mexico\u2019s Expanded Equivalency Agreement for Medical Devices: Key Implications<\/span><\/a><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-31\"><span data-contrast=\"auto\">The updated process promises approval timelines of 30 business days, enhancing access to the Mexican market.<\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-32\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3 class=\"ai-optimize-33\"><b><span data-contrast=\"auto\">Additional Implications: Accelerated Timelines for Ordinary Process<\/span><\/b><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h3>\n<p>&nbsp;<\/p>\n<p class=\"ai-optimize-34\"><span data-contrast=\"auto\">Interestingly, <\/span><b><span data-contrast=\"auto\">Article 5<\/span><\/b><span data-contrast=\"auto\"> of the Simplification Agreement suggests that the ordinary registration process will now offer timelines comparable to the equivalency agreement route. <\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-35\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-36\"><span data-contrast=\"auto\">Estimated processing times by device class are:\u00a0<\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-37\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<table data-tablestyle=\"MsoTableGrid\" data-tablelook=\"1696\">\n<tbody>\n<tr>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-38\"><b><span data-contrast=\"auto\">Device Class<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<\/td>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-39\"><b><span data-contrast=\"auto\">Estimated Timeline<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-40\"><span data-contrast=\"auto\">Class I\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<\/td>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-41\"><span data-contrast=\"auto\">20 business days<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-42\"><span data-contrast=\"auto\">Class I (Low Risk)<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<\/td>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-43\"><span data-contrast=\"auto\">15 business days<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-44\"><span data-contrast=\"auto\">Class II<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<\/td>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-45\"><span data-contrast=\"auto\">25 business days<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-46\"><span data-contrast=\"auto\">Class III<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<\/td>\n<td data-celllook=\"0\">\n<p class=\"ai-optimize-47\"><span data-contrast=\"auto\">35 business days<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"ai-optimize-48\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-49\"><em><strong>These timelines are indicative and may be subject to extension in practice.\u00a0<\/strong><\/em><\/p>\n<p class=\"ai-optimize-50\"><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3 class=\"ai-optimize-51\"><b><span data-contrast=\"auto\">Conclusions<\/span><\/b><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h3>\n<p>&nbsp;<\/p>\n<p class=\"ai-optimize-52\"><span data-contrast=\"auto\">The Simplification Agreement marks a pivotal shift in Mexico\u2019s regulatory landscape for medical devices. With its official implementation on <\/span><b><span data-contrast=\"auto\">October 3, 2025<\/span><\/b><span data-contrast=\"auto\">, stakeholders must reassess their registration strategies to align with the new framework and leverage available efficiencies.<\/span><span data-ccp-props=\"{&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-53\"><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p class=\"ai-optimize-54\"><span data-contrast=\"auto\">If you have <\/span><b><span data-contrast=\"auto\">questions or comments<\/span><\/b><span data-contrast=\"auto\"> regarding this new equivalency agreement, feel free to <\/span><a href=\"mailto:contact@veraqueconsulting.com\"><span data-contrast=\"none\">contact Veraque<\/span><\/a><span data-contrast=\"auto\"> . You can also\u00a0 <\/span><a href=\"https:\/\/www.linkedin.com\/build-relation\/newsletter-follow?entityUrn=7281002133808635907\"><span data-contrast=\"none\">subscribe to our LinkedIn newsletter<\/span><\/a><span data-contrast=\"auto\"> to stay connected, and ensure you never miss regulatory insights.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>When seeking sanitary registration for medical devices in Mexico through COFEPRIS, companies have traditionally followed one of two routes: the ordinary process or the fast-track equivalency agreements. From those, the equivalency pathway has become a central topic of discussion following the implementation of the Expanded Equivalency Agreement. \u00a0 \u00a0 This article outlines the implications of [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":4082,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,390],"tags":[],"class_list":["post-4081","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-equivalency-agreement","category-mexico"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Simplification Agreement Impact on Equivalency Pathways - Veraque Mexico<\/title>\n<meta name=\"description\" content=\"Explore the August 2025 Simplification Agreement\u2019s impact on Mexico\u2019s medical device equivalency pathways and COFEPRIS registration changes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Simplification Agreement: Impact on Mexico\u2019s Medical Device Equivalency Pathways\" \/>\n<meta property=\"og:description\" content=\"Explore the August 2025 Simplification Agreement\u2019s impact on Mexico\u2019s medical device equivalency pathways and COFEPRIS registration changes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/\" \/>\n<meta property=\"og:site_name\" content=\"Veraque Mexico\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-02T14:51:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-02T14:53:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2025\/09\/simplification_agreement_mexico.png\" \/>\n\t<meta property=\"og:image:width\" content=\"940\" \/>\n\t<meta property=\"og:image:height\" content=\"788\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"mkt1\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mkt1\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/\"},\"author\":{\"name\":\"mkt1\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#\\\/schema\\\/person\\\/3f760cd8f7128ca81c70930dcfcc1e44\"},\"headline\":\"Simplification Agreement: Impact on Mexico\u2019s Medical Device Equivalency Pathways\",\"datePublished\":\"2025-09-02T14:51:10+00:00\",\"dateModified\":\"2025-09-02T14:53:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/09\\\/simplification_agreement_mexico.png\",\"articleSection\":[\"Equivalency Agreement\",\"Mexico\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/\",\"url\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/\",\"name\":\"Simplification Agreement Impact on Equivalency Pathways - Veraque Mexico\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/09\\\/simplification_agreement_mexico.png\",\"datePublished\":\"2025-09-02T14:51:10+00:00\",\"dateModified\":\"2025-09-02T14:53:29+00:00\",\"description\":\"Explore the August 2025 Simplification Agreement\u2019s impact on Mexico\u2019s medical device equivalency pathways and COFEPRIS registration changes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/#primaryimage\",\"url\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/09\\\/simplification_agreement_mexico.png\",\"contentUrl\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2025\\\/09\\\/simplification_agreement_mexico.png\",\"width\":940,\"height\":788,\"caption\":\"Simplification Agreement Impact Equivalency Pathways, update button\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/simplification-agreement-impact-on-equivalency-pathways\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Simplification Agreement: Impact on Mexico\u2019s Medical Device Equivalency Pathways\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#website\",\"url\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/\",\"name\":\"Veraque Mexico\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#organization\",\"name\":\"Veraque Mexico\",\"url\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2019\\\/11\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2019\\\/11\\\/logo.png\",\"width\":450,\"height\":105,\"caption\":\"Veraque Mexico\"},\"image\":{\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/#\\\/schema\\\/person\\\/3f760cd8f7128ca81c70930dcfcc1e44\",\"name\":\"mkt1\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ce58fed175315752b10e7604ce713dd9a941e8c2800a89102729df3452b82236?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ce58fed175315752b10e7604ce713dd9a941e8c2800a89102729df3452b82236?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ce58fed175315752b10e7604ce713dd9a941e8c2800a89102729df3452b82236?s=96&d=mm&r=g\",\"caption\":\"mkt1\"},\"url\":\"https:\\\/\\\/veraqueconsulting.com\\\/mx\\\/author\\\/mkt1\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Simplification Agreement Impact on Equivalency Pathways - Veraque Mexico","description":"Explore the August 2025 Simplification Agreement\u2019s impact on Mexico\u2019s medical device equivalency pathways and COFEPRIS registration changes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/","og_locale":"en_US","og_type":"article","og_title":"Simplification Agreement: Impact on Mexico\u2019s Medical Device Equivalency Pathways","og_description":"Explore the August 2025 Simplification Agreement\u2019s impact on Mexico\u2019s medical device equivalency pathways and COFEPRIS registration changes.","og_url":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/","og_site_name":"Veraque Mexico","article_published_time":"2025-09-02T14:51:10+00:00","article_modified_time":"2025-09-02T14:53:29+00:00","og_image":[{"width":940,"height":788,"url":"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2025\/09\/simplification_agreement_mexico.png","type":"image\/png"}],"author":"mkt1","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mkt1","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/#article","isPartOf":{"@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/"},"author":{"name":"mkt1","@id":"https:\/\/veraqueconsulting.com\/mx\/#\/schema\/person\/3f760cd8f7128ca81c70930dcfcc1e44"},"headline":"Simplification Agreement: Impact on Mexico\u2019s Medical Device Equivalency Pathways","datePublished":"2025-09-02T14:51:10+00:00","dateModified":"2025-09-02T14:53:29+00:00","mainEntityOfPage":{"@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/"},"wordCount":413,"publisher":{"@id":"https:\/\/veraqueconsulting.com\/mx\/#organization"},"image":{"@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/#primaryimage"},"thumbnailUrl":"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2025\/09\/simplification_agreement_mexico.png","articleSection":["Equivalency Agreement","Mexico"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/","url":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/","name":"Simplification Agreement Impact on Equivalency Pathways - Veraque Mexico","isPartOf":{"@id":"https:\/\/veraqueconsulting.com\/mx\/#website"},"primaryImageOfPage":{"@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/#primaryimage"},"image":{"@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/#primaryimage"},"thumbnailUrl":"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2025\/09\/simplification_agreement_mexico.png","datePublished":"2025-09-02T14:51:10+00:00","dateModified":"2025-09-02T14:53:29+00:00","description":"Explore the August 2025 Simplification Agreement\u2019s impact on Mexico\u2019s medical device equivalency pathways and COFEPRIS registration changes.","breadcrumb":{"@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/#primaryimage","url":"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2025\/09\/simplification_agreement_mexico.png","contentUrl":"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2025\/09\/simplification_agreement_mexico.png","width":940,"height":788,"caption":"Simplification Agreement Impact Equivalency Pathways, update button"},{"@type":"BreadcrumbList","@id":"https:\/\/veraqueconsulting.com\/mx\/simplification-agreement-impact-on-equivalency-pathways\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/veraqueconsulting.com\/mx\/"},{"@type":"ListItem","position":2,"name":"Simplification Agreement: Impact on Mexico\u2019s Medical Device Equivalency Pathways"}]},{"@type":"WebSite","@id":"https:\/\/veraqueconsulting.com\/mx\/#website","url":"https:\/\/veraqueconsulting.com\/mx\/","name":"Veraque Mexico","description":"","publisher":{"@id":"https:\/\/veraqueconsulting.com\/mx\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/veraqueconsulting.com\/mx\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/veraqueconsulting.com\/mx\/#organization","name":"Veraque Mexico","url":"https:\/\/veraqueconsulting.com\/mx\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/veraqueconsulting.com\/mx\/#\/schema\/logo\/image\/","url":"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2019\/11\/logo.png","contentUrl":"https:\/\/veraqueconsulting.com\/mx\/wp-content\/uploads\/sites\/3\/2019\/11\/logo.png","width":450,"height":105,"caption":"Veraque Mexico"},"image":{"@id":"https:\/\/veraqueconsulting.com\/mx\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/veraqueconsulting.com\/mx\/#\/schema\/person\/3f760cd8f7128ca81c70930dcfcc1e44","name":"mkt1","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ce58fed175315752b10e7604ce713dd9a941e8c2800a89102729df3452b82236?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ce58fed175315752b10e7604ce713dd9a941e8c2800a89102729df3452b82236?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce58fed175315752b10e7604ce713dd9a941e8c2800a89102729df3452b82236?s=96&d=mm&r=g","caption":"mkt1"},"url":"https:\/\/veraqueconsulting.com\/mx\/author\/mkt1\/"}]}},"_links":{"self":[{"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/posts\/4081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/comments?post=4081"}],"version-history":[{"count":0,"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/posts\/4081\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/media\/4082"}],"wp:attachment":[{"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/media?parent=4081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/categories?post=4081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veraqueconsulting.com\/mx\/wp-json\/wp\/v2\/tags?post=4081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}